HALO Breast Cytological Evaluation Test Overview
The HALO® Breast Cytological Evaluation Test is FDA approved for the collection of nipple aspirate fluid for cytological evaluation. The collected fluid can be used in the determination and/or differentiation of normal versus pre-malignant versus malignant cells.
Incorporating Halo into routine practice will enable physicians and patients to monitor cellular changes within breast ducts earlier, before they develop into larger, potentially cancerous lesions.
The HALO System is a simple, reliable method for NAF collection. NAF analysis is an objective assessment of a patient's breast health and can detect early warning signs of ductal cellular changes. Regular assessment and tracking of cellular changes in the milk ducts, where most breast cancer begins, enables clinicians and patients to take control of breast health.
The HALO Breast Cytological Evaluation Test is the only fully automated, noninvasive NAF collection system specifically designed for use in a busy primary care setting.
The HALO System provides important benefits to clinicians and patients:For clinicians:
Click to view
New Patient Pamphlet
HALO system and components
Back to top